Skip to main content

Market Overview

10 Short Squeeze Candidates If The Market Rally Continues

10 Short Squeeze Candidates If The Market Rally Continues

Despite a rising number of U.S. coronavirus (COVID-19) cases and deaths, the SPDR S&P 500 ETF Trust (NYSE: SPY) has rallied 12.6% in the past two weeks. The country may not yet be through the worst of the coronavirus outbreak, but investors may already see a light at the end of the tunnel.

If the recent rally continues, short sellers that bet on a prolonged market sell-off could be caught in a tricky situation. S3 Partners analyst Ihor Dusaniwsky said Monday that short sellers are already feeling some major pain in the past couple of weeks. If the market rally continues, he said traders could soon see some significant short squeezes.

“Stocks that performed well and were ‘losers’ for the short side will be in line for a squeeze as shorts take on even more losses if a market rally truly takes hold,” Dusaniwsky said.

Benzinga is covering every angle of how the coronavirus affects the financial world. For daily updates, sign up for our coronavirus newsletter.

Overall, the S&P 500 is still down 9.8% since March 1, so there aren’t many stocks that have been losers for short sellers in that time. However, Dusaniwsky said each of the following stocks have cost short sellers at least $100 million in losses since March 1, and each has averaged more than $600 million in short interest over that time.

10 Short Squeeze Candidates

Here are stocks that Dusaniwsky said are short squeeze candidates if the market rally continues, sorted by price performance since March 1:

  1. Citrix Systems, Inc. (NASDAQ: CTXS), +41.3%
  2. Moderna Inc (NASDAQ: MRNA), +29.1%
  3. Zscaler Inc (NASDAQ: ZS), +19.2%
  5. Hormel Foods Corp (NYSE: HRL), +16.2%
  6. General Mills, Inc. (NYSE: GIS), +15%
  7. Kroger Co (NYSE: KR), +12.2%
  8. Teladoc Health Inc (NYSE: TDOC), +11%
  9. Zoom Video Communications Inc (NASDAQ: ZM), +10.9%
  10. Gilead Sciences, Inc. (NASDAQ: GILD), +8.8%

See Also: Stock Borrow Costs: A Short Seller's Worst Enemy

Benzinga’s Take

It’s worth noting that as the market has rallied, many of these top-performing stocks in March have cooled, seemingly lowering the chances of a short squeeze in the near term. The three stocks mentioned above with the most gains so far in the month of April are General Mills, Moderna and Digital Realty Trust.

Do you agree with this take? Email with your thoughts.

Photo via Wikimedia

Latest Ratings for MRNA

Mar 2021Chardan CapitalMaintainsBuy
Feb 2021Brookline CapitalMaintainsBuy
Feb 2021Morgan StanleyMaintainsEqual-Weight

View More Analyst Ratings for MRNA
View the Latest Analyst Ratings


Related Articles (CTXS + MRNA)

View Comments and Join the Discussion!

Posted-In: Coronavirus Ihor Dusaniwsky S3 PartnersAnalyst Color Long Ideas Top Stories Analyst Ratings Trading Ideas Best of Benzinga

Latest Ratings

NLSNMorgan StanleyMaintains27.0
MSFTMorgan StanleyMaintains290.0
KRMorgan StanleyMaintains29.0
GPSMorgan StanleyMaintains29.0
BURLMorgan StanleyMaintains290.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at